A Study of ImmunoPet Imaging Using 89Zr-DFO-REGN5054 in Adult Participants With Solid Cancers Treated With Cemiplimab
Clinical trial NCT05259709 · RECRUITING
Trial details
- NCT number
- NCT05259709
- Sponsor
- Regeneron Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-07
- Primary completion
- 2027-01-06
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.